Literature DB >> 15154085

Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function.

Hwancheol Son1, Kwanjin Park, Soo-Woong Kim, Jae-Seung Paick.   

Abstract

AIM: To investigate the reasons for discontinuations of sildenafil after the successful restoration of erectile function.
METHODS: One hundred fifty six patients, whose scores of erectile function domain of the 15-item International Index of Erectile Function (IIEF) increased to 26 or more after sildenafil medication, were included in this study. Six-months after the first sildenafil prescription, compliance to medication and the reason for discontinuity were reviewed by chart or surveyed by telephone.
RESULTS: Fifty-four (34.6 %) of the 156 successfully treated patients discontinued sildenafil medication. The reasons for discontinuance were shortcomings in the partners' or patients' emotional readiness for the restoration of sexual life after long-term abstinence (37.0 %), fear of possible side effects (18.5 %), recovery of spontaneous erection (14.8 %), postponement of ED treatment because of co-morbid disease treatment (11.1 %), unwillingness to accept drug-dependent erection (7.4 %), high drug cost (3.7 %), unacceptability of planned sexual activity (3.7 %) and lack of sexual interest (3.7 %).
CONCLUSION: The reasons for discontinuing sildenafil medication were primarily emotional or relationship-oriented, which indicates that simple recovery of a rigid erection is insufficient to restore sexual activity. More education about the effects of drug and the counseling of both partners is recommended to promote the successful recovery of sexual activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15154085

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  16 in total

Review 1.  Daily dosing of PDE5 inhibitors: where does it fit in?

Authors:  King Chien Joe Lee; Gerald B Brock
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

2.  Effects of chronic treatment with the eNOS stimulator Impaza on penis length and sexual behaviors in rats with a high baseline of sexual activity.

Authors:  X Chu; E S Zhavbert; J L Dugina; I A Kheyfets; S A Sergeeva; O I Epstein; A Agmo
Journal:  Int J Impot Res       Date:  2013-03-14       Impact factor: 2.896

3.  Evaluation of a multi-herb supplement for erectile dysfunction: a randomized double-blind, placebo-controlled study.

Authors:  Gaurang R Shah; Manojkumar V Chaudhari; Suresh B Patankar; Shrikant V Pensalwar; Vilas P Sabale; Navneet A Sonawane
Journal:  BMC Complement Altern Med       Date:  2012-09-15       Impact factor: 3.659

Review 4.  Current status of penile rehabilitation after radical prostatectomy.

Authors:  Jae Heon Kim; Seung Wook Lee
Journal:  Korean J Urol       Date:  2015-01-30

5.  Comparison of the simplified International Index of Erectile Function (IIEF-5) in patients of erectile dysfunction with different pathophysiologies.

Authors:  Zhengyan Tang; Dongjie Li; Xiaobo Zhang; Lu Yi; Xiangsheng Zhu; Xiangyang Zeng; Yuxin Tang
Journal:  BMC Urol       Date:  2014-07-05       Impact factor: 2.264

6.  Preference for and adherence to oral phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction.

Authors:  Konstantinos Giannitsas; Angelis Konstantinopoulos; Christos Patsialas; Petros Perimenis
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

Review 7.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

8.  Structural equation modeling of the proximal-distal continuum of adherence drivers.

Authors:  Colleen A McHorney; Ning Jackie Zhang; Timothy Stump; Xiaoquan Zhao
Journal:  Patient Prefer Adherence       Date:  2012-11-09       Impact factor: 2.711

Review 9.  Sexual dysfunction in 2013: Advances in epidemiology, diagnosis and treatment.

Authors:  King Chien Joe Lee; Nader Fahmy; Gerald B Brock
Journal:  Arab J Urol       Date:  2013-07-23

10.  Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients.

Authors:  S-C Kim; Y-S Lee; K-K Seo; G-W Jung; T-H Kim
Journal:  Int J Impot Res       Date:  2013-12-05       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.